理气破血逐瘀法治疗气滞血瘀型子宫肌瘤的疗效分析

An efficacy analysis of treating hysteromyoma by the Liqi Poxue Zhuyu therapy

目的:观察理气破血逐瘀法治疗气滞血瘀型子宫肌瘤的临床疗效。方法:将气滞血瘀型子宫肌瘤患者90例分为中西结合组(自拟中药方加米非司酮)和西医组(米非司酮)各,45例,治疗3月后观察并比较两组的疗效、血中孕激素变化和随访6个月的复发率。结果:中西医结合组总有效率达88.9%,高于西医组的80.0%,差异不具有统计学意义(P>0.05);两组患者经治疗后血FSH、E2和P均有不同程度下降,与治疗前相比差异均有统计学意义(P<0.05);治疗后两组组间对比,中西结合组的血FSH、E2和P均低于西医组,差异均有统计学意义(P<0.05);随访6个月,中西医结合组复发率为10.0%,低于西医组的30.5%,差异有统计学意义(P<0.05)。结论:采用理气破血逐瘀法治疗气滞血瘀型子宫肌瘤疗效确切,略优于米非司酮治疗,且复发率低,值得临床应用。

Objective： To observe the clinical efficacy of the Liqi Poxue Zhuyu therapy on hysteromyoma. Methods： 90 cases of hysteromyoma were randomly divided into the integrative medicine group （self-prescription ＋ mifepristone） and the western group （mifepristone）, 45 cases for each. After 3 months of treatment, efficacy of both groups and blood progesterone were observed. There was tracked recurrence rate whit in six months. Results： The total efficiency of 88.9% in the integrative medicine group was higher than 80.0% in the western group. The difference was not statistically significant （P＆gt;0.05）. The blood FSH, E2 and P were decreased after treatment, and the difference was statistically significant （P〈0.05）. Two groups were compared. The blood FSH, E2 and P in the integrative medicine group were less than those in the western group, the difference was statistically significant （P〈0.05）. The recurrence rate in the integrative medicine group was 10.0% in six months, less than the 30.5% in the western group, （P〈0.05）. Conclusion： There has an obvious efficacy of the Liqi Poxue Zhuyu therapy on hysteromyoma, was better than mifepristone treatment, lower recurrence rate, worthy of clinical application.